In conclusion, our study found no significant differences in protein levels related to the RAS between healthy controls and COVID-19 cases nor among clinical outcomes, aligning with previous research suggesting that RAS components, such as ACE, may not be reliable biomarkers for COVID-19 severity. Here, ACE is linked to COVID-19.